Skip to content
Screener

Guardian Pharmacy Services GRDN Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$63K+150%
Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
$159M+8.2%
PACS Group logo
PACS GroupPACS
$5.02M-16.9%
GHC
Graham HoldingsGHC
$34.52M+5.7%

Other financials

Income statement

See full
Revenue$351.8M+2.2%
Gross profit$80.0M+17.5%
Operating income$20.6M+64.1%
Net income$21.9M+142%
EPS (diluted)$0.34+143%

Balance sheet

See full
Cash & equivalents$89.8M+377%
Total debt$35.2M+4.6%
Total equity$257.6M+43.4%
Total assets$443.6M+24.5%

Cash flow

See full
Operating cash flow$30.0M+50.6%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.78B+121%
Enterprise value$2.72B+114%
P/E42.1×
P/S1.9×+1.0×

Profitability

See full
Gross margin21.6%+2.0pp
Operating margin5.8%
Net margin4.5%+2.8pp

Returns & leverage

See full
Return on equity30.1%
Debt / equity0.1×-0.1×
Current ratio1.7×+0.5×

Where this comes from

Reported directly by Guardian Pharmacy Services in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Guardian Pharmacy Services’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338074
(In thousands, except share amounts)December 31, 2025June 30, 2026
Equity:
Class A common stock - 700,000,000 shares authorized, par value $0.001; 36,253,744 and 49,792,884 shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively3650
Class B common stock - 100,000,000 shares authorized, par value $0.001; 27,066,890 and 13,539,453 shares issued and outstanding as of December 31, 2025 and June 30, 2026, respectively2713
Additional paid-in capital139,353144,040
Retained earnings66,343101,510
Non-controlling interests12,16512,029
Total equity217,924257,642
Total liabilities and equity$412,658$443,578

ITEM 1. Financial Statements

FAQ

What is Guardian Pharmacy Services's noncontrolling interests in subsidiaries?
Guardian Pharmacy Services (GRDN) reported noncontrolling interests in subsidiaries of $12.03M in Q2 2026.
How has Guardian Pharmacy Services's noncontrolling interests in subsidiaries changed year-over-year?
Guardian Pharmacy Services's noncontrolling interests in subsidiaries increased by 19.0% year-over-year, from $10.11M to $12.03M.
What is the long-term trend for Guardian Pharmacy Services's noncontrolling interests in subsidiaries?
Over 2 years (2023 to 2025), Guardian Pharmacy Services's noncontrolling interests in subsidiaries has grown at a -38.0% compound annual growth rate (CAGR), from $31.65M to $12.17M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Guardian Pharmacy Services's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude